	Zobowiązania Handlowe		Data
Acadia Pharmaceuticals	USD 10.9M	10.84M	2025-12
Agios Pharmaceuticals	USD 18.36M	1.2M	2025-12
Akebia Therapeutics	USD 21.18M	11.1M	2025-12
Almirall	EUR 258.05M	58.66M	2025-12
Alnylam Pharmaceuticals	USD 115.72M	1.87M	2025-12
Amarin	USD 36.71M	8M	2025-09
Ardelyx	USD 18.39M	3.29M	2025-09
Astellas Pharma	JPY 181.95B	13.3B	2025-12
AstraZeneca	USD 25.28B	252M	2025-12
Charles River Laboratories	USD 148.8M	20.82M	2025-12
Coherus Biosciences	USD 24.89M	12.73M	2025-09
Emergent BioSolutions	USD 112.2M	500K	2023-12
Esperion Therapeutics	USD 77.51M	2.81M	2025-09
Exact Sciences	USD 175.87M	46.51M	2025-12
Halozyme Therapeutics	USD 20.9M	5.54M	2025-12
Incyte	USD 1.63B	1.46B	2025-12
Ironwood Pharmaceuticals	USD 1.61M	224K	2025-09
Karyopharm Therapeutics	USD 5.39M	2.8M	2025-09
Lexicon Pharmaceuticals	USD 5.9M	4.79M	2025-06
MacroGenics	USD 5.94M	1.28M	2025-09
Moderna	USD 317M	50M	2025-12
Myriad Genetics	USD 31.8M	900K	2025-09
Pacira	USD 15.15M	2.54M	2025-12
PTC Therapeutics	USD 45.49M	8.87M	2025-12
Puma Biotechnology	USD 6.39M	962K	2025-09
Sarepta Therapeutics	USD 280.84M	186.83M	2025-12
Takeda	JPY 467.59B	28.61B	2025-12
Ultragenyx Pharmaceutical	USD 40.57M	6.33M	2025-09
Vanda Pharmaceuticals	USD 39.09M	33.28M	2024-12

Ironwood Pharmaceuticals Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.